Medical News Today5d
Anti-amyloid drug may help reduce the risk of early-onset Alzheimer's by 50%
An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...
What to Expect From Alzheimer’s Disease Treatment, According to Experts
Alzheimer’s disease doesn’t have a cure, meaning no treatment can reverse the damage that’s already occurred in the brain.
Researchers find a hint at how to delay Alzheimer’s symptoms. Now they have to prove it
An experimental treatment appears to postpone Alzheimer's symptoms in some people genetically destined to get the disease at ...
Scientists Announce Possible Breakthrough in Delaying Alzheimer’s
Research announced today is the first of its kind to suggest that anti-amyloid drugs can delay or even stop the progression of symptoms in people with early-onset Alzheimer's.
Rolling Out3d
Early behavioral changes that may signal Alzheimer’s
Alzheimer's disease progresses gradually, with subtle behavioral changes often appearing long before a formal diagnosis.
Greek Reporter2d
Scientists Say New Drug Could Help Prevent Alzheimer’s
An experimental drug has shown promise in preventing Alzheimer’s for people at higher risk of developing the disease.
New drug could reduce risk of early-onset Alzheimer’s disease
The results boost hopes similar treatments being developed to target more common forms of Alzheimer’s – that appear when ...
Alzheimer’s-related dementia could be prevented by experimental drug, researchers say
For some people with a high risk of Alzheimer's who received a drug called gantenerumab for eight years, their risk of ...
Treating Alzheimer’s Challenges with Zentara’s Early Detection Strategy
Since Alzheimer’s advanced stage has no cure right now, the entire focus of Zentara is on prevention. For this purpose, it has identified two goals: make early Alzheimer’s diagnosis cheaper and give ...
New Atlas4d
Alzheimer’s prevention hope as drug cuts deadly disease onset in half
A long-term human trial has found that a discontinued drug halved the presentation of early-onset Alzheimer's disease in ...
Rolling Out2d
Alzheimer’s tests show troubling racial accuracy gap
New research shows Alzheimer's blood tests are 90% accurate for white patients but only 73% for Black patients, raising ...
Alector: Q4 Of 2025 FTD-GRN Treatment Data Is Important Inflection Point
AL002 misses Phase 2 goal in early Alzheimer's. Key Phase 3 data for latozinemab in 2025. Click here to read why ALEC is a ...